Physician profile
Michaela E Beynon
NPI 1881117075
$2,332.87
in general payments reported to CMS, 2019-2025
19 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.33 · 2020: $31.76 · 2021: $206 · 2022: $120 · 2023: $127 · 2024: $1,624 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,352 · Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,352.24 |
| Food and Beverage | $579.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,410.81 | 2024 | |
| Pfizer INC. | $143.63 | 2021-2025 | |
| Organon LLC | $112.46 | 2024-2025 | Nexplanon |
| Abbvie INC. | $110.54 | 2020-2023 | Lo Loestrin Fe |
| Ethicon US, LLC | $78.42 | 2022-2025 | Enseal, Pds, Dermabond Prineo |
| Shield Therapeutics INC | $76.41 | 2024-2025 | |
| Coopersurgical, INC. | $67.44 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Merck Sharp & Dohme LLC | $63.85 | 2019-2021 | |
| Exact Sciences Corporation | $59.21 | 2023 | Cologuard Collection Kit |
| Exeltis, USA INC. | $39.05 | 2021-2022 | |
| Novo Nordisk INC | $29.94 | 2024 | Wegovy |
| Mayne Pharma Commercial LLC | $22.99 | 2024 | |
| Avion Pharmaceuticals | $21.59 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $19.90 | 2021 | |
| Astellas Pharma US INC | $18.21 | 2025 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $17.61 | 2022 | |
| Clovis Oncology, INC. | $15.33 | 2021 | |
| Lsi Solutions INC | $14.63 | 2025 | Fornisee |
| Tesaro, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michaela Beynon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.